Drug lookup
Drug reference

isosorbide dinitrate/hydralazine

Vasodilator · Agent for heart failure

VasodilatorAgent for heart failure
CDSCO approved
EXCRETION
not curated
INTERACTIONS
none in our sources
PREGNANCY
not curated

Mechanism

Isosorbide dinitrate, an organic nitrate, dilates large blood vessels (venous capacitance and arterial conductance vessels), primarily reducing preload. Hydralazine is a direct vasodilator whose mechanism of action is unresolved but may prevent nitrate tolerance by reducing ROS-mediated inactivation of nitric oxide.

Indications

heart failure in African Americans

Dosing

Adult
Fixed combination formulation contains 37.5 mg hydralazine and 20 mg ISDN and is uptitrated to a target dose of two tablets, thrice daily.

Contraindications

  • PDE5 inhibitors

Side effects

Common
dizzinessheadachenauseaflushingpalpitationstachycardiaangina pectoris
Serious
  • hypotension
  • drug-induced lupus-like syndrome

Related guidelines

Other Vasodilator drugs

Ask House about isosorbide dinitrate/hydralazine

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team